Current Protein Identity:P54252 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1YZB Solution structure of the Josephin domain of Ataxin-3 Deposited 2005-02-28 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–182(182 aa) Fragment:N-terminal domain of Ataxin-3
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.5;298 K;Ionic strength (raw mmCIF value) 20mM sodium phosphate;Pressure ambient
NMR sample composition 0.4mM of Josephin 15N, 13C; 20mM sodium phosphate buffer (pH 6.5); 90% H2O, 10% D2O | 90% H2O/10% D2O
Resolution not provided
2AGA De-ubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain Deposited 2005-07-26 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–185(185 aa) Fragment:Josephin domain
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.4;298 K;Ionic strength (raw mmCIF value) 20 mM KPO4;Pressure 1
NMR sample composition 2mM Josephin domain U-15N,13C; 20mM phosphate buffer pH 6.4; 90% H2O, 10% D2O | 90% H2O/10% D2O
Resolution not provided
2DOS Structural basis for the recognition of Lys48-linked polyubiquitin chain by the Josephin domain of ataxin-3, a putative deubiquitinating enzyme Deposited 2006-05-03 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–171(171 aa) Fragment:Josephin domain
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 7;303 K;Ionic strength (raw mmCIF value) 10mM Sodium phosphate buffer;Pressure 1
NMR sample composition 1.2mM Josephin domain U-15N,13C; 10mM Sodium phosphate buffer; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition 1.2mM Josephin domain U-15N,13C; 10mM Sodium phosphate buffer; 99% D2O | 99% D2O
Resolution not provided
2JRI Solution structure of the Josephin domain of Ataxin-3 in complex with ubiquitin molecule. Deposited 2007-06-27 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 1–182(182 aa) Fragment:N-terminal domain of ataxin-3 sequence database residues 1-182
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.5;298 K;Ionic strength (raw mmCIF value) 0.01;Pressure ambient
NMR sample composition 0.1 - 0.3 mM [U-15N] protein, 0.1 -0.3 mM [U-13C; U-15N] protein, 0.1-0.3 mM protein, 0.1-0.3 mM [U-13C; U-15N; U-2H] protein, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
2KLZ Solution Structure of the Tandem UIM Domain of Ataxin-3 Complexed with Ubiquitin Deposited 2009-07-12 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 222–263(42 aa) Fragment:UIM1 and UIM 2 domain, UNP residues 222-263
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.5;298 K;Pressure ambient
NMR sample composition 1 mM [U-100% 15N] protein-1, 20 mM sodium phosphate-2, 100 mM sodium chloride-3, 0.02 % sodium azide-4, 4 mM ubiquitin-5, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 1 mM [U-100% 13C; U-100% 15N] protein-6, 20 mM sodium phosphate-7, 100 mM sodium chloride-8, 0.02 % sodium azide-9, 4 mM ubiquitin-10, 90% H2O/10% D2O | 90% H2O/10% D2O
Resolution not provided
4WTH Ataxin-3 Carboxy Terminal Region - Crystal C2 (triclinic) Deposited 2014-10-30 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 278–324(47 aa) Fragment:MBP residues 27-392 (UNP) + Ataxin-3 C-terminal region (UNP residues 278-324)
Not recorded ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;277 K;24% PEG5000 MME, 0.9 M sodium acetate, 0.06 M imidazole, pH 8.0, 0.1 M zinc acetate
Resolution 2.25 Å R-free 0.250
4WTH Ataxin-3 Carboxy Terminal Region - Crystal C2 (triclinic) Deposited 2014-10-30 Assembly 2 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 278–324(47 aa) Fragment:MBP residues 27-392 (UNP) + Ataxin-3 C-terminal region (UNP residues 278-324)
Not recorded ZN ZINC ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;277 K;24% PEG5000 MME, 0.9 M sodium acetate, 0.06 M imidazole, pH 8.0, 0.1 M zinc acetate
Resolution 2.25 Å R-free 0.250
4YS9 Ataxin-3 Carboxy-Terminal Region - Crystal C1 (tetragonal) Deposited 2015-03-16 Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 278–324(47 aa) Fragment:MBP residues 27-392 (UNP) + Ataxin-3 C-terminal region (UNP residues 278-324)
Not recorded ZN ZINC ION × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;278 K;25% PEG5000 MME, 1.0 M sodium acetate, 0.1 M imidazole, pH 8.0, 0.1 M zinc acetate
Resolution 2.00 Å R-free 0.223